125 related articles for article (PubMed ID: 9336743)
1. Adoptive immunotherapy with tumor-cytotoxic macrophages derived from recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) mobilized peripheral blood monocytes.
Hennemann B; Rehm A; Kottke A; Meidenbauer N; Andreesen R
J Immunother; 1997 Sep; 20(5):365-71. PubMed ID: 9336743
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte-macrophage colony-stimulating factor treatment on phenotype, cytokine release and cytotoxicity of circulating blood monocytes and monocyte-derived macrophages.
Hennemann B; Kreutz M; Rehm A; Andreesen R
Br J Haematol; 1998 Sep; 102(5):1197-203. PubMed ID: 9753045
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
[TBL] [Abstract][Full Text] [Related]
4. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects.
Bukowski RM; Murthy S; McLain D; Finke J; Andresen S; Tubbs R; Bauer L; Gibson V; Budd GT; Thomassen MJ
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):267-74. PubMed ID: 8334111
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
Link H; Boogaerts MA; Carella AM; Ferrant A; Gadner H; Gorin NC; Harabacz I; Harousseau JL; Hervé P; Holldack J
Blood; 1992 Nov; 80(9):2188-95. PubMed ID: 1421390
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE
J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.
Manfredi R; Mastroianni A; Coronado O; Chiodo F
J Chemother; 1996 Jun; 8(3):214-20. PubMed ID: 8808719
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor.
Lesimple T; Moisan A; Guillé F; Leberre C; Audran R; Drenou B; Toujas L
J Immunother; 2000; 23(6):675-9. PubMed ID: 11186156
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Bishop MR; Anderson JR; Jackson JD; Bierman PJ; Reed EC; Vose JM; Armitage JO; Warkentin PI; Kessinger A
Blood; 1994 Jan; 83(2):610-6. PubMed ID: 7904489
[TBL] [Abstract][Full Text] [Related]
11. Large-scale production of human tumorcytotoxic macrophages grown from blood monocytes of cancer patients.
Brugger W; Scheibenbogen C; Krause S; Andreesen R
Cancer Detect Prev; 1991; 15(5):407-12. PubMed ID: 1751952
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.
Everly JJ; Lonial S
Expert Opin Biol Ther; 2005 Mar; 5(3):293-311. PubMed ID: 15833068
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
Chang AE; Aruga A; Cameron MJ; Sondak VK; Normolle DP; Fox BA; Shu S
J Clin Oncol; 1997 Feb; 15(2):796-807. PubMed ID: 9053507
[TBL] [Abstract][Full Text] [Related]
14. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
[TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.
Triozzi PL; Tucker F; Benzies T; Balcerzak SP
Bone Marrow Transplant; 1996 Jul; 18(1):47-52. PubMed ID: 8831995
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Rabinowitz J; Petros WP; Stuart AR; Peters WP
Blood; 1993 May; 81(9):2452-9. PubMed ID: 7683220
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of granulocyte-macrophage colony-stimulating factor production during human monocyte-to-macrophage maturation.
Krause SW; Kreutz M; Zenke G; Andreesen R
Ann Hematol; 1992 Apr; 64(4):190-5. PubMed ID: 1374650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
